Literature DB >> 20573788

Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion.

Ebe D'Adamo1, Veronika Northrup, Ram Weiss, Nicola Santoro, Bridget Pierpont, Mary Savoye, Grace O'Malley, Sonia Caprio.   

Abstract

BACKGROUND: Recently, the deleterious metabolic effects of visceral fat [visceral adipose tissue (VAT)] deposition were challenged, and liver fat emerged as having a key independent role in the modulation of cardiometabolic risk factors.
OBJECTIVE: We explored the relation between liver fat content and VAT in 3 ethnic groups and evaluated whether the ethnic differences in the distributions of lipoprotein concentrations and sizes were associated with the hepatic fat fraction (HFF), VAT, or both.
DESIGN: In a multiethnic group of 33 white, 33 African American, and 33 Hispanic obese adolescents with normal glucose tolerance, we measured VAT and HFF by using magnetic resonance imaging. Fasting lipoprotein particle number and size were measured by using nuclear magnetic resonance spectroscopy. To assess the association between VAT and HFF, we categorized VAT into tertiles.
RESULTS: In each ethnic group, HFF values increased between successive tertiles of VAT. After multivariate adjustment and in comparison with the 2 other groups, African Americans showed lower triglyceride (P = 0.001) and higher HDL (P = 0.03) concentrations, lower concentrations of total (P = 0.007), large (P = 0.005), and medium (P lt 0.0001) VLDL, but higher concentrations of large HDL particles (P = 0.01) and larger HDL (P = 0.005). In multivariate linear models, independent of ethnicity, VAT was a significant predictor for large HDL (P = 0.003) and total small LDL (P = 0.001) concentrations, whereas HFF significantly predicted large VLDL (P = 0.03) concentrations.
CONCLUSION: Liver fat accretion, independent of VAT, may play a role in the ethnic differences seen in large VLDL particles. This trial was registered at clinicaltrials.gov as NCT00536250.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573788      PMCID: PMC2921534          DOI: 10.3945/ajcn.2010.29270

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  33 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

2.  Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation.

Authors:  Iva Miljkovic-Gacic; Clareann H Bunker; Robert E Ferrell; Candace M Kammerer; Rhobert W Evans; Alan L Patrick; Lewis H Kuller
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

3.  Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound.

Authors:  Mark Fishbein; Fernando Castro; Sailaja Cheruku; Shaily Jain; Brian Webb; Theodore Gleason; W Ross Stevens
Journal:  J Clin Gastroenterol       Date:  2005-08       Impact factor: 3.062

4.  Differences in the relation of obesity to serum triacylglycerol and VLDL subclass concentrations between black and white children: the Bogalusa Heart Study.

Authors:  David S Freedman; Barbara A Bowman; James D Otvos; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Am J Clin Nutr       Date:  2002-05       Impact factor: 7.045

5.  Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study.

Authors:  Wei Chen; Sathanur R Srinivasan; Eric Boerwinkle; Gerald S Berenson
Journal:  Atherosclerosis       Date:  2003-07       Impact factor: 5.162

6.  Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents.

Authors:  Catherine W Yeckel; Ram Weiss; James Dziura; Sara E Taksali; Sylvie Dufour; Tania S Burgert; William V Tamborlane; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors.

Authors:  Fida Bacha; Rola Saad; Neslihan Gungor; Janine Janosky; Silva A Arslanian
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  Visceral fat and liver fat are independent predictors of metabolic risk factors in men.

Authors:  Thanh-Binh Nguyen-Duy; Milton Z Nichaman; Timothy S Church; Steven N Blair; Robert Ross
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-01-28       Impact factor: 4.310

9.  Obesity and the metabolic syndrome in children and adolescents.

Authors:  Ram Weiss; James Dziura; Tania S Burgert; William V Tamborlane; Sara E Taksali; Catherine W Yeckel; Karin Allen; Melinda Lopes; Mary Savoye; John Morrison; Robert S Sherwin; Sonia Caprio
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  Splanchnic lipolysis in human obesity.

Authors:  Soren Nielsen; ZengKui Guo; C Michael Johnson; Donald D Hensrud; Michael D Jensen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

View more
  31 in total

1.  Interethnic Variation in Lipid Profiles: Implications for Underidentification of African-Americans at risk for Metabolic Disorders.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Expert Rev Endocrinol Metab       Date:  2014-01-10

2.  Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.

Authors:  Hideo Makimura; Meghan N Feldpausch; Takara L Stanley; Noelle Sun; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

3.  Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls.

Authors:  Peter M Wolfgram; Ellen L Connor; Jennifer L Rehm; Jens C Eickhoff; Scott B Reeder; David B Allen
Journal:  Obesity (Silver Spring)       Date:  2013-09-17       Impact factor: 5.002

4.  Prediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peers.

Authors:  Sheela N Magge; Divya Prasad; Dorit Koren; Paul R Gallagher; Emile R Mohler; Nicolas Stettler; Lorraine E Levitt Katz; Daniel J Rader
Journal:  J Pediatr       Date:  2012-05-22       Impact factor: 4.406

5.  Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.

Authors:  Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir
Journal:  Mayo Clin Proc       Date:  2014-03-07       Impact factor: 7.616

6.  Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.

Authors:  Nicola Santoro; Clarence K Zhang; Hongyu Zhao; Andrew J Pakstis; Grace Kim; Romy Kursawe; Daniel J Dykas; Allen E Bale; Cosimo Giannini; Bridget Pierpont; Melissa M Shaw; Leif Groop; Sonia Caprio
Journal:  Hepatology       Date:  2011-12-18       Impact factor: 17.425

7.  In Nonobese Girls, Waist Circumference as a Predictor of Insulin Resistance Is Comparable to MRI Fat Measures and Superior to BMI.

Authors:  Peter M Wolfgram; Ellen L Connor; Jennifer L Rehm; Jens C Eickhoff; Wei Zha; Scott B Reeder; David B Allen
Journal:  Horm Res Paediatr       Date:  2015-09-10       Impact factor: 2.852

Review 8.  Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Glob Heart       Date:  2017-05-17

9.  Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial.

Authors:  Catherine L Davis; Norman K Pollock; Jennifer L Waller; Jerry D Allison; B Adam Dennis; Reda Bassali; Agustín Meléndez; Colleen A Boyle; Barbara A Gower
Journal:  JAMA       Date:  2012-09-19       Impact factor: 56.272

10.  The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study.

Authors:  C Lorenzo; A J Hanley; M J Rewers; S M Haffner
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.